Genentech reveals updates from Phase 3 IMagyn050 clinical trial

Genentech reveals updates from Phase 3 IMagyn050 clinical trial

Published: 20 hours ago By Saipriya Iyer

Genentech has recently announced that its Phase III IMagyn050 study did not meet the primary endpoint of PFS (progression-free survival). In the study, the company added the Tecentriq ® (atezolizumab) to the Avastin® ....

4e Brands issues voluntary recall of hand sanitizers in United States

4e Brands North America, LLC has reportedly issued a voluntary recall of ten bottle sizes of the hand sanitizers due to the potential methanol (wood alcohol) presence. Risks factors associated with substantial exposure to the undeclared me....

CTI-Medidata partner to adopt Remote Source Review in clinical trials

CTI Clinical Trial and Consulting Services will reportedly adopt Remote Source Review of Medidata. Medidata is the end-to-end solutions provider to support the clinical trials. This contract research organization will use the service to upg....

NIMS begins subject enrollment for Phase 1 trial of COVID-19 vaccine

Nizam’s Institute of Medical Science (NIMS) has recently commenced the enrollment of subjects for its Phase 1 clinical trials of the COVID-19 vaccine. It is the 1st indigenous coronavirus vaccine candidate developed in India. Followi....

Walmart to compete Amazon Prime with new subscription service, Walmart

U.S retail giant, Walmart Inc. has recently joined the race against Amazon with its latest subscription service, Walmart+. Similar to Amazon Prime, the new subscription service will endow Walmart customers with access to same-day ....

Regeneron begins late-stage trial of its coronavirus antibody cocktail

Renowned American biopharmaceutical company, Regeneron Pharmaceuticals, has reportedly announced that it has started late-stage clinical trials of its proprietary antibody cocktail to assess its effectiveness in treating and preventing COVI....

China completes 2 launches in 3-day span with Gaofen & Shiyan-6

China has recently launched its classified Shiyan-6 (02) satellite, following the launch of Gaofen, which is a ‘multimode’ Earth observation satellite, into orbit 2 days earlier. These two launches will mark the 16th and 17th or....

Industry Updates